Kaneka Eurogenetic expands Liège production base

International biotech company Eurogentec has announced the construction of a new production zone at its site in Seraing, Liège.

The expansion will enable the company to manufacture biopharmaceutical products on a larger scale.

Japanese company Kaneka acquired a majority stake seven years ago in Eurogentec, which was founded in 1985 by two Liège University researchers.

The company employs 339 people, of whom 260 are based in Liège. It is one of the most important suppliers of genomic and proteomic kits, used in the final phase of clinic trials.

Pascale Delcomminette, general manager of the Walloon Export and Foreign Investment Agency (AWEX), welcomed the investment.

“This announcement strengthens our vision and our continual efforts to reinforce and show the attractiveness of Wallonia for the development of R&D and high-tech production,” she said.

“During a visit to Japan last October, I had the pleasure of meeting Mr Kimikazu Sugawara, the president of the board of administrators of Kaneka in Osaka, in order to reinforce the positive collaboration between AWEX and the Kaneka group.”